New Parkinson's drug candidate PDM608 passes first safety check in healthy volunteers
NCT ID NCT05950906
First seen Nov 18, 2025 · Last updated Jun 17, 2026 · Updated 31 times
Summary
This early-stage study tested a new drug called PDM608 in 64 healthy adults to see if it is safe and how the body processes it. The goal was not to treat Parkinson's disease yet, but to gather important safety information before testing it in patients. Participants received either the drug or a placebo and were monitored for side effects, lab changes, and heart activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quotient Sciences-Miami, Inc
Miami, Florida, 33126, United States
Conditions
Explore the condition pages connected to this study.